New malaria vaccine trial could stop recurrent fever in its tracks
⭐️ VACCINE ⭐️
Not yet recruiting
This study tests an experimental vaccine called PvCS/Montanide ISA-51 to see if it can safely prevent malaria caused by the P. vivax parasite. About 72 healthy adults aged 18-50 will receive three shots over four months, then be exposed to infected mosquitoes under medical superv…
Phase: PHASE2 • Sponsor: Malaria Vaccine and Drug Development Center • Aim: ⭐️ VACCINE ⭐️
Last updated May 11, 2026 02:40 UTC